STAT Plus: U.S. officials lash out at the Dutch government for moves that ‘undermine’ pharma patent rights

In an unusual move, the U.S. Embassy in the Netherlands is taking the Dutch government to task for policies that would purportedly undermine patent rights held by drug makers, drawing criticism from consumer advocates who argue such declarations place pharmaceutical industry profits over patients.

Late last month, the embassy issued a missive criticizing Dutch officials for plans to expand compulsory licensing and pharmaceutical compounding, which would “send a clear message” to companies that patents in the Netherlands “can be undermined or circumvented for short-term financial benefits.”

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: U.S. officials lash out at the Dutch government for moves that ‘undermine’ pharma patent rights »